San Diego-based Astute Medical, a provider of biomarker-based medical diagnostics technology, reports this morning that it has raised $40.4M in a Series C funding round. The round was led by MPM Capital, and also included new investor Kaiser Permanente Ventures. The firm's existing investors, De Novo Ventures, Delphi Ventures, Domain Associates and Johnson & Johnson Development Corporation, also participated. Astute Medical said it will use the new funding to begin commercializing its first product, in addition to expanding research, development, and validation of its diagnostic tests.
Top NewsThursday, June 7, 2012
Astute Medical Raises $40.4M